RecallDepth
Class II Ongoing

Sandoz Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 1000-count bottles, Rx Only, Finished Drug Product Manufactured by: Lek Pharmaceuticals d.d. SI-1526 Ljubljana,Sovenia for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5207-10.

Company
Sandoz Inc
Recall Initiated
November 1, 2018
Posted
December 5, 2018
Recall Number
D-0359-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
170 HDPE bottles
Firm Location
Princeton, NJ, United States

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Distribution

OH, PR

Lot / Code Info

Lot #: JB8912; Exp. 06/2020

More recalls by Sandoz Inc

View all recalls by this company →

Other recent Class II Drug recalls